BlackRock Inc. - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,189,568
+4.3%
1,404,403
-0.1%
0.00%0.0%
Q2 2023$21,283,903
+592.4%
1,405,806
+563.2%
0.00%
Q1 2023$3,073,784
+20.9%
211,985
+12.8%
0.00%
Q4 2022$2,541,679
+9.3%
187,994
+27.4%
0.00%
Q3 2022$2,326,000
+194.1%
147,593
+127.1%
0.00%
Q2 2022$791,000
-81.1%
64,999
-85.4%
0.00%
Q1 2022$4,184,000
-45.0%
445,520
+0.2%
0.00%
Q4 2021$7,609,000444,4260.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders